Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Sterile Injectable Manufacturing: SOP for Managing Waste Disposal during Injectable Manufacturing – V 2.0

Posted on By

Sterile Injectable Manufacturing: SOP for Managing Waste Disposal during Injectable Manufacturing – V 2.0

Standard Operating Procedure for Managing Waste Disposal during Injectable Manufacturing


Department Sterile Injectable Manufacturing
SOP No. SOP/SIM/133/2025
Supersedes SOP/SIM/133/2022
Page No. Page 1 of 15
Issue Date 24/06/2025
Effective Date 26/06/2025
Review Date 24/06/2026

1. Purpose

This SOP defines the systematic process for handling, segregation, storage, and disposal of various types of waste generated during the manufacturing of sterile injectable products. It ensures adherence to GMP, safety, and environmental regulations.

2. Scope

This SOP applies to

all types of waste generated in sterile manufacturing areas including:

  • Non-hazardous and general waste
  • Hazardous waste (e.g., chemical residues, cleaning solvents)
  • Biomedical waste (e.g., used PPE, microbial samples)
  • Sharps and broken glass
  • Packaging waste

3. Responsibilities

  • Manufacturing Operators: Segregate and label waste properly at the source.
  • Production Supervisor: Ensure daily disposal and log maintenance.
  • QA Executive: Audit waste handling and ensure regulatory compliance.
  • EHS Officer: Arrange final disposal and maintain disposal records.
See also  Sterile Injectable Manufacturing: SOP for Intradermal Injection Batch Manufacturing - V 2.0

4. Accountability

The Head of Manufacturing and EHS Head are jointly accountable for compliance with this SOP.

5. Procedure

5.1 Waste Classification

  1. Classify waste into the following categories:
    • Solid General Waste: Packaging materials, PPE, used documents
    • Liquid Waste: Unused solutions, rinses
    • Chemical Waste: Residuals of cleaning agents or solvents
    • Biohazard Waste: Microbiological testing leftovers
    • Sharps: Broken glass, needles

5.2 Waste Segregation

  1. Use color-coded bins:
    • Yellow: Infectious waste
    • Red: Plastic waste (autoclavable)
    • White (puncture proof): Sharps
    • Black: General waste
  2. Do not mix waste types in the same container.

5.3 Waste Labeling

  1. Affix a “WASTE” label on all bins and bags with the following:
    • Date of collection
    • Type of waste
    • Operator initials

5.4 Waste Storage

  1. Store segregated waste in designated waste holding areas.
  2. Ensure temporary storage does not exceed 48 hours.
See also  Sterile Injectable Manufacturing: SOP for Functional Testing of Prefilled Syringes - V 2.0

5.5 Waste Disposal

  1. Dispose of general waste through approved municipal services.
  2. Hazardous waste to be sent to certified incineration or disposal contractors.
  3. Autoclave biohazard waste before disposal.
  4. Document disposal in the Waste Disposal Register (Annexure-1).

5.6 Cleaning of Waste Areas

  1. Clean waste bins with 0.5% sodium hypochlorite daily.
  2. Disinfect storage areas weekly using appropriate agents.

5.7 Emergency Handling

  1. In case of spill:
    • Evacuate non-involved personnel.
    • Wear appropriate PPE.
    • Contain and neutralize chemical spills as per MSDS.
    • Report the incident to the EHS team immediately.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • EHS: Environment, Health & Safety
  • MSDS: Material Safety Data Sheet
  • PPE: Personal Protective Equipment

7. Documents

  1. Waste Disposal Register – Annexure-1
  2. Biohazard Waste Autoclave Log – Annexure-2
  3. Chemical Spill Report – Annexure-3

8. References

  • Biomedical Waste Management Rules, 2016 (India)
  • ICH Q9 – Quality Risk Management
  • WHO GMP Guidelines for Pharmaceutical Manufacturing
See also  Sterile Injectable Manufacturing: SOP for Monitoring Critical Control Points in Machine Operations - V 2.0

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation Manufacturing Executive QA Executive Head QA
Department Production Quality Assurance Quality Assurance

11. Annexures

Annexure-1: Waste Disposal Register

Date Waste Type Quantity Disposal Method Disposed By
23/06/2025 General Waste 25 kg Municipal Ramesh Kumar

Annexure-2: Biohazard Waste Autoclave Log

Date Waste Description Autoclave Time Temperature Verified By
22/06/2025 Used Swabs 45 min 121°C Sunita Reddy

Annexure-3: Chemical Spill Report

Date Location Description Action Taken Reported By
20/06/2025 Dispensing Booth Acetic acid spill Neutralized and cleaned Ajay Mehta

Revision History

Revision Date Revision No. Details Reason Approved By
01/04/2022 1.0 Initial release New SOP QA Head
24/06/2025 2.0 Added chemical spill response and annexure Annual Review QA Head
Injectables V 2.0 Tags:Aseptic processing SOP, Aseptic technique in sterile manufacturing, Cleanroom SOP for injectables, SOP for ampoule sealing, SOP for autoclave sterilization, SOP for container closure integrity testing, SOP for environmental monitoring in aseptic area, SOP for gowning in cleanroom, SOP for in-process checks in sterile manufacturing, SOP for injectable formulation, SOP for lyophilizer operation, SOP for sterile filtration, SOP for sterilization validation, SOP for vial filling, SOP for visual inspection of injectables, Sterile area cleaning SOP, Sterile filling line SOP, Sterile injectable quality control SOP, Sterile injection SOP, Sterile manufacturing procedure

Post navigation

Previous Post: Gel Manufacturing: SOP for Visual Inspection of Gel-Filled Tubes – V 2.0
Next Post: Cleaning Performed Inconsistently with SOP: GMP Non-Adherence Explained

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version